These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30306748)

  • 21. Seasonal variation in circulating group 2 innate lymphoid cells in mugwort-allergic asthmatics during and outside pollen season.
    Miao Q; Wang Y; Liu YG; Ren YX; Guan H; Li Z; Xu W; Xiang L
    Allergy Asthma Clin Immunol; 2018; 14():6. PubMed ID: 29449864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of
    Huang R; Qin R; Hu Q; Zhu Z; Liu Y; Luo T; Li J
    Allergy Asthma Immunol Res; 2020 Sep; 12(5):844-858. PubMed ID: 32638564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of IL-18 on Group 2 Innate Lymphoid Cells in Allergic Rhinitis.
    Li C; Xu Y; Luo X; Chen F
    Iran J Immunol; 2021 Sep; 18(3):188-194. PubMed ID: 34596583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum-specific IgE and allergen immunotherapy in allergic children.
    Tosca M; Silvestri M; Accogli A; Rossi GA; Ciprandi G
    Immunotherapy; 2014; 6(1):29-33. PubMed ID: 24341881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imbalanced distribution of group 2 innate lymphoid cells (ILCs) and ILC precursors in peripheral blood of patients with primary biliary cholangitis.
    Li H; Zhan H; Cheng L; Yan S; Wang L; Li Y
    Scand J Immunol; 2022 Jul; 96(1):e13166. PubMed ID: 35315090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severity and disease control before house dust mite immunotherapy initiation: ANTARES a French observational survey.
    Demoly P; Broué-Chabbert A; Wessel F; Chartier A
    Allergy Asthma Clin Immunol; 2016; 12():13. PubMed ID: 27069487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuromedin U Induces Activation of Peripheral Group 2 Innate Lymphoid Cells through the ERK Pathway in Allergic Rhinitis Patients.
    Qi X; Zhuo H; Wang Y; Ren F; Xue J; An Y; Zhao C
    Int Arch Allergy Immunol; 2023; 184(1):1-11. PubMed ID: 36244335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allergic rhinitis: the eligible candidate to mite immunotherapy in the real world.
    Ciprandi G; Natoli V; Puccinelli P; Incorvaia C;
    Allergy Asthma Clin Immunol; 2017; 13():11. PubMed ID: 28239397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advocacy of Precision Allergy Molecular Diagnosis in Decision Making for the Eligibility of Customized Allergen Immunotherapy.
    González-Pérez R; Poza-Guedes P; Pineda F; Sánchez-Machín I
    Curr Issues Mol Biol; 2023 Dec; 45(12):9976-9984. PubMed ID: 38132469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration of circulating innate lymphoid cells in patients with atherosclerotic cerebral infarction.
    Li Q; Liu M; Fu R; Cao Q; Wang Y; Han S; Hu W; Li H; Hu C; Wu L; Zhang L; Deng J; Wang Y
    Am J Transl Res; 2018; 10(12):4322-4330. PubMed ID: 30662674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase Cθ controls type 2 innate lymphoid cell and T
    Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
    J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence in allergen immunotherapy: A longitudinal, prescription data-based real-world analysis.
    Pfaar O; Richter H; Sager A; Miller C; Müller T; Jutel M
    Clin Transl Allergy; 2023 May; 13(5):e12245. PubMed ID: 37227419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The analysis of Th2 cell subsets in house dust mite allergic rhinitis patients after sublingual immunotherapy].
    Ihara F; Sakurai D; Okamoto Y
    Nihon Yakurigaku Zasshi; 2019; 154(1):12-16. PubMed ID: 31308344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cells are necessary for ILC2 activation in house dust mite-induced allergic airway inflammation in mice.
    Li BW; de Bruijn MJ; Tindemans I; Lukkes M; KleinJan A; Hoogsteden HC; Hendriks RW
    Eur J Immunol; 2016 Jun; 46(6):1392-403. PubMed ID: 27062360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological parameters as biomarkers of response to MicroCrystalline Tyrosine-adjuvanted mite immunotherapy.
    Justicia JL; Padró C; Roger A; Moreno F; Rial MJ; Parra A; Valero A; Malet A; Teniente A; Boronat A; Torán-Barona C
    World Allergy Organ J; 2021 Jun; 14(6):100545. PubMed ID: 34178239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro T-lymphocyte response and house dust mite-induced bronchoconstriction.
    Chang JH; Chan H; Quirce S; Green T; Noertjojo K; Lam S; Frew A; Keown P; Chan-Yeung M
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):922-31. PubMed ID: 8939155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma.
    Agache I; Lau S; Akdis CA; Smolinska S; Bonini M; Cavkaytar O; Flood B; Gajdanowicz P; Izuhara K; Kalayci O; Mosges R; Palomares O; Papadopoulos NG; Sokolowska M; Angier E; Fernandez-Rivas M; Pajno G; Pfaar O; Roberts GC; Ryan D; Sturm GJ; van Ree R; Varga EM; van Wijk RG; Yepes-Nuñez JJ; Jutel M
    Allergy; 2019 May; 74(5):855-873. PubMed ID: 31095767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innate lymphoid cells are increased in systemic lupus erythematosus.
    Hou M; Liu S
    Clin Exp Rheumatol; 2019; 37(4):676-679. PubMed ID: 30789153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chinese Guideline on allergen immunotherapy for allergic rhinitis.
    Bao Y; Chen J; Cheng L; Guo Y; Hong S; Kong W; Lai H; Li H; Li H; Li J; Li T; Lin X; Liu S; Liu Z; Lou H; Meng J; Qiu Q; Shen K; Tang W; Tao Z; Wang C; Wang X; Wei Q; Xiang L; Xie H; Xu Y; Zhang G; Zhang Y; Zheng Y; Zhi Y; Chen D; Hong H; Li Q; Liu L; Meng Y; Wang N; Wang Y; Zhou Y; Zhang L;
    J Thorac Dis; 2017 Nov; 9(11):4607-4650. PubMed ID: 29268533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sialic acid-modified der p 2 allergen exerts immunomodulatory effects on human PBMCs.
    Keumatio Doungtsop BC; Nardini E; Kalay H; Versteeg SA; Lübbers J; van Barneveld G; Li ERJ; van Vliet SJ; van Ree R; de Jong EC; van Kooyk Y
    J Allergy Clin Immunol Glob; 2024 Feb; 3(1):100193. PubMed ID: 38187864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.